UK Scientists Accelerate Ebola Vaccine Development Using COVID Platform

UK researchers are rushing to develop a new Ebola vaccine utilizing the viral vector platform from the Oxford/AstraZeneca COVID-19 jab. This rapid pivot leverages existing technology to potentially provide a faster defense against the Congo outbreak. The development underscores the critical need for adaptable medical infrastructure to respond to emerging global threats.